Medicus Pharma Ltd.
MDCX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001997296
No open-market purchases or sales by Medicus Pharma Ltd. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $1.18M in total; no superinvestor holds it.
Other share classesMDCXW
13F holders, Q3 2025
Institutional positions in Medicus Pharma Ltd. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- −1 vs. Q2 2025
- Shares held
- 2.12M
- −86.6K (−3.9%) vs. Q2 2025
- Total value
- $4.91M
- −$1.69M (−25.6%) vs. Q2 2025
- New holders
- 7
- 3 more added
- Sold out
- 8
- 5 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MDCX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $1.18M |
| Q1 2026 | 21 | $301.6K |
| Q4 2025 | 21 | $6.03M |
| Q3 2025 | 20 | $4.91M |
| Q2 2025 | 21 | $6.60M |
| Q1 2025 | 7 | $11.4M |
| Q4 2024 | 3 | $3.74M |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Medicus Pharma Ltd.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Interchange Capital Partners, LLC | 1,586,871 | $3.67M | 0.72% | 00.0% | Unchanged |
| Yorkville Advisors Global, LP | 230,000 | $532.5K | 0.21% | +124,160+117.3% | Added |
| Private Advisor Group, LLC | 151,500 | $350.7K | 0.00% | +5,500+3.8% | Added |
| Bryn Mawr Trust Co | 25,622 | $59.3K | 0.00% | +25,622 | New |
| Brave Asset Management Inc | 20,000 | $46.3K | 0.01% | +20,000 | New |
| LPL Financial LLC | 18,751 | $43.4K | 0.00% | +18,751 | New |
| May Hill Capital, LLC | 17,811 | $41.2K | 0.01% | −17,811−50.0% | Reduced |
| BlackRock, Inc. | 16,216 | $37.5K | 0.00% | +452+2.9% | Added |
| Advisor Group Holdings, Inc. | 14,000 | $31.4K | 0.00% | 00.0% | Unchanged |
| Base Wealth Management LLC | 11,543 | $26.7K | 0.02% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 10,882 | $25.0K | 0.00% | +10,882 | New |
| UBS Group AG | 6,957 | $16.1K | 0.00% | −23,969−77.5% | Reduced |
| Morgan Stanley | 5,968 | $13.8K | 0.00% | −5,762−49.1% | Reduced |
| Larson Financial Group LLC | 1,000 | $2.31K | 0.00% | −2,125−68.0% | Reduced |
| FNY Investment Advisers, LLC | 1,000 | $2.00K | 0.00% | +1,000 | New |
| Jones Financial Companies LLLP | 400 | $1.05K | 0.00% | 00.0% | Unchanged |
| DAGCO, Inc. | 349 | $808 | 0.00% | −1−0.3% | Reduced |
| EverSource Wealth Advisors, LLC | 300 | $695 | 0.00% | +300 | New |
| Citigroup Inc | 222 | $514 | 0.00% | +222 | New |
| Wells Fargo & Company | 75 | $174 | 0.00% | 00.0% | Unchanged |
| Guyasuta Investment Advisors Inc | 0 | $0 | 0.00% | −76,911−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −53,385−100.0% | Sold out |
| SeaCrest Wealth Management, LLC | 0 | $0 | 0.00% | −46,624−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −41,099−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −13,788−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −11,099−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Parkside Financial Bank & Trust | 0 | $0 | 0.00% | −400−100.0% | Sold out |